A Randomized, Double-blind, Placebo-controlled, Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied Four Times Daily in Subjects Experiencing Acute Delayed Onset Muscle Soreness (DOMS) of the Lower Limbs

Trial Profile

A Randomized, Double-blind, Placebo-controlled, Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied Four Times Daily in Subjects Experiencing Acute Delayed Onset Muscle Soreness (DOMS) of the Lower Limbs

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Apr 2016

At a glance

  • Drugs Diclofenac (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 29 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 02 Dec 2014 Planned number of patients changed from 86 to 102 as reported by ClinicalTrials.gov record.
    • 27 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top